ADGRA1

gene
On this page

Also known as KIAA1828

Summary

ADGRA1 (adhesion G protein-coupled receptor A1, HGNC:13838) is a protein-coding gene on chromosome 10q26.3, encoding Adhesion G protein-coupled receptor A1 (Q86SQ6). Orphan receptor.

This gene encodes a protein that belongs to the adhesion family of G-protein-coupled receptors. Members of this family function in several sensory systems and regulate blood pressure, immune responses, food intake and development. A similar protein in rodents is thought to play a role in in the regulation of neuronal signaling pathways. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.

Source: NCBI Gene 84435 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 124 total — 1 pathogenic
  • Druggable target: yes
  • MANE Select transcript: NM_001083909

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13838
Approved symbolADGRA1
Nameadhesion G protein-coupled receptor A1
Location10q26.3
Locus typegene with protein product
StatusApproved
AliasesKIAA1828
Ensembl geneENSG00000197177
Ensembl biotypeprotein_coding
OMIM612302
Entrez84435

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000392606, ENST00000392607, ENST00000864054

RefSeq mRNA: 2 — MANE Select: NM_001083909 NM_001083909, NM_001291085

CCDS: CCDS41580, CCDS76362

Canonical transcript exons

ENST00000392607 — 7 exons

ExonStartEnd
ENSE00001512487133087924133088138
ENSE00001622464133096974133097101
ENSE00001680963133098640133098763
ENSE00001931650133128329133131675
ENSE00002209139133088708133088912
ENSE00002494549133127233133127331
ENSE00003514083133102697133102842

Expression profiles

Bgee: expression breadth broad, 94 present calls, max score 87.87.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.8990 / max 41.5640, expressed in 168 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
1077450.6984150
1077460.104556
1077470.038925
1077440.033921
1077430.023411

Top tissues by expression

221 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right frontal lobeUBERON:000281087.87gold quality
Brodmann (1909) area 9UBERON:001354086.62gold quality
anterior cingulate cortexUBERON:000983586.44gold quality
dorsolateral prefrontal cortexUBERON:000983485.82gold quality
prefrontal cortexUBERON:000045185.09gold quality
hypothalamusUBERON:000189883.70gold quality
neocortexUBERON:000195083.37gold quality
lateral nuclear group of thalamusUBERON:000273683.32gold quality
frontal cortexUBERON:000187083.18gold quality
primary visual cortexUBERON:000243682.14gold quality
cerebral cortexUBERON:000095681.74gold quality
amygdalaUBERON:000187680.75gold quality
ventricular zoneUBERON:000305379.32gold quality
middle temporal gyrusUBERON:000277179.05gold quality
ganglionic eminenceUBERON:000402378.61gold quality
Ammon’s hornUBERON:000195477.89gold quality
forebrainUBERON:000189076.36gold quality
occipital lobeUBERON:000202176.18gold quality
temporal lobeUBERON:000187176.16gold quality
C1 segment of cervical spinal cordUBERON:000646975.52gold quality
pancreatic ductal cellCL:000207974.87silver quality
brainUBERON:000095574.74gold quality
superior frontal gyrusUBERON:000266173.87gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047373.26gold quality
Brodmann (1909) area 23UBERON:001355473.26gold quality
substantia nigraUBERON:000203872.57gold quality
spinal cordUBERON:000224072.56gold quality
Brodmann (1909) area 46UBERON:000648371.92gold quality
nucleus accumbensUBERON:000188271.05gold quality
caudate nucleusUBERON:000187371.00gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.78

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

81 targeting ADGRA1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-6748-5P100.0065.811057
HSA-MIR-4455100.0065.481587
HSA-MIR-8485100.0077.574731
HSA-MIR-9-5P100.0072.282361
HSA-MIR-4481100.0066.421669
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-806899.9873.852376
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-6793-5P99.9765.95758
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-659-3P99.8570.691620
HSA-MIR-5010-3P99.8370.602357
HSA-MIR-684499.8270.692423
HSA-MIR-808099.8267.521342
HSA-MIR-674599.7465.331321
HSA-MIR-320299.6667.702737
HSA-MIR-4666B99.6468.691282
HSA-MIR-613299.6065.831554
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-24-3P99.5969.971934
HSA-MIR-1212299.5669.331672
HSA-MIR-4649-3P99.5666.901783
HSA-MIR-190A-5P99.5471.45933
HSA-MIR-190B-5P99.5471.40925
HSA-MIR-486-3P99.5166.821901
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-468899.4864.68828

Literature-anchored findings (GeneRIF, showing 3)

  • Studies indicate that the orthologs of GP123 in mouse and rat play a role in the regulation of neuronal signaling pathways. (PMID:17212699)
  • Adhesion GPR123 is an indicator for recurrence and prognosis in bladder cancer. (PMID:33945147)
  • Essential Role of Adhesion GPCR, GPR123, for Human Pluripotent Stem Cells and Reprogramming towards Pluripotency. (PMID:36672239)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusAdgra1ENSMUSG00000025475
rattus_norvegicusAdgra1ENSRNOG00000054955

Paralogs (42): CALCR (ENSG00000004948), GIPR (ENSG00000010310), ADGRA2 (ENSG00000020181), CALCRL (ENSG00000064989), GLP2R (ENSG00000065325), ADGRF5 (ENSG00000069122), ADGRL1 (ENSG00000072071), ADCYAP1R1 (ENSG00000078549), SCTR (ENSG00000080293), VIPR2 (ENSG00000106018), CRHR2 (ENSG00000106113), GHRHR (ENSG00000106128), ADGRD1 (ENSG00000111452), GLP1R (ENSG00000112164), ADGRG6 (ENSG00000112414), VIPR1 (ENSG00000114812), ADGRL2 (ENSG00000117114), CRHR1 (ENSG00000120088), ADGRB2 (ENSG00000121753), ADGRE5 (ENSG00000123146), ADGRE2 (ENSG00000127507), ADGRE3 (ENSG00000131355), ADGRB3 (ENSG00000135298), PTH2R (ENSG00000144407), ADGRG7 (ENSG00000144820), ADGRL3 (ENSG00000150471), ADGRA3 (ENSG00000152990), ADGRF1 (ENSG00000153292), ADGRF4 (ENSG00000153294), ADGRG4 (ENSG00000156920), ADGRG5 (ENSG00000159618), PTH1R (ENSG00000160801), ADGRL4 (ENSG00000162618), EVA1C (ENSG00000166979), ADGRF3 (ENSG00000173567), ADGRG2 (ENSG00000173698), ADGRE1 (ENSG00000174837), ADGRD2 (ENSG00000180264), ADGRB1 (ENSG00000181790), ADGRG3 (ENSG00000182885)

Protein

Protein identifiers

Adhesion G protein-coupled receptor A1Q86SQ6 (reviewed: Q86SQ6)

Alternative names: G-protein coupled receptor 123

All UniProt accessions (1): Q86SQ6

UniProt curated annotations — full annotation on UniProt →

Function. Orphan receptor.

Subcellular location. Membrane.

Similarity. Belongs to the G-protein coupled receptor 2 family. Adhesion G-protein coupled receptor (ADGR) subfamily.

Isoforms (3)

UniProt IDNamesCanonical?
Q86SQ6-33yes
Q86SQ6-11
Q86SQ6-22

RefSeq proteins (2): NP_001077378, NP_001278014 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000832GPCR_2_secretin-likeFamily
IPR017981GPCR_2-like_7TMDomain
IPR017983GPCR_2_secretin-like_CSConserved_site
IPR051963Adhesion_GPCR_AFamily

Pfam: PF00002

UniProt features (30 total): topological domain 8, transmembrane region 7, region of interest 3, compositionally biased region 3, splice variant 3, sequence variant 3, chain 1, glycosylation site 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86SQ6-F164.300.30

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 75

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 49 (showing top): SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN, GOCC_POSTSYNAPSE, GOCC_SYNAPSE, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOCC_GLUTAMATERGIC_SYNAPSE, GOCC_NEURON_TO_NEURON_SYNAPSE, MIR6867_5P, MIR5010_3P, MIR4731_5P, MIR6722_3P, MIR5589_3P, MIR190A_5P, MIR1909_3P

GO Biological Process (3): signal transduction (GO:0007165), cell surface receptor signaling pathway (GO:0007166), G protein-coupled receptor signaling pathway (GO:0007186)

GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), transmembrane signaling receptor activity (GO:0004888)

GO Cellular Component (4): plasma membrane (GO:0005886), postsynaptic density (GO:0014069), membrane (GO:0016020), glutamatergic synapse (GO:0098978)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
signal transduction2
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
G protein-coupled receptor activity1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
signaling receptor activity1
membrane1
cell periphery1
asymmetric synapse1
postsynaptic specialization1
cellular anatomical structure1
synapse1

Protein interactions and networks

STRING

818 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ADGRA1SCTRP47872817
ADGRA1KNDC1Q76NI1665
ADGRA1ADGRG5Q8IZF4639
ADGRA1ADGRF2PQ8IZF7615
ADGRA1ADGRG3Q86Y34612
ADGRA1ADGRG7Q96K78603
ADGRA1ADGRD2Q7Z7M1595
ADGRA1ADGRF1Q5T601584
ADGRA1ADGRF3Q8IZF5573
ADGRA1ADGRF4Q8IZF3566
ADGRA1ADGRG1Q9Y653559
ADGRA1ADGRF5Q8IZF2542
ADGRA1GPR68Q15743530
ADGRA1CDH24Q86UP0518
ADGRA1GPR162Q16538510

IntAct

125 interactions, top by confidence:

ABTypeScore
DLG1ADGRA1psi-mi:“MI:0915”(physical association)0.610
ADGRA1DLG1psi-mi:“MI:0407”(direct interaction)0.610
ADGRA1SNX27psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1MAST2psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1MAGI3psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1MAGI2psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1SYNJ2BPpsi-mi:“MI:0407”(direct interaction)0.440
ADGRA1DLG2psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1DLG4psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1DLG3psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1LNX2psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1PDZD7psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1PTPN3psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1MAST1psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1SCRIBpsi-mi:“MI:0407”(direct interaction)0.440
ADGRA1SNTB1psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1MAGI1psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1SNTA1psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1RHPN1psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1TAX1BP3psi-mi:“MI:0407”(direct interaction)0.440
ADGRA1PDZRN4psi-mi:“MI:0407”(direct interaction)0.440

BioGRID (1): GPR123 (Positive Genetic)

ESM2 similar proteins: A0A2R9YJI3, A3KFU9, A6QLU6, B2ZHY2, B4XF06, D3Z7H4, D3ZK93, D4A6L0, E1BBQ2, O43194, O75204, P51810, P70259, P82352, Q14714, Q16538, Q17QQ5, Q2T9K0, Q3UN16, Q49LS8, Q4V922, Q5E9H8, Q5MNU5, Q5T848, Q5U431, Q62147, Q6NV75, Q6PI62, Q6UXU4, Q7RTS5, Q7TQN9, Q80ZU9, Q86SQ6, Q8BGE9, Q8BGP5, Q8C419, Q8C4G9, Q8K0Z9, Q8NBV4, Q8VHW3

Diamond homologs: E7FBY6, Q7TT36, Q86SQ6, Q8C4G9, Q8IWK6, Q91ZV8, Q96PE1, S4X0Q8, P48960, Q9BY15, G5EFX6

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 80 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Ras activation upon Ca2+ influx through NMDA receptor556.0×1e-06
Unblocking of NMDA receptors, glutamate binding and activation553.3×1e-06
Negative regulation of NMDA receptor-mediated neuronal transmission553.3×1e-06
Long-term potentiation546.6×2e-06
Assembly and cell surface presentation of NMDA receptors839.8×2e-09
Neurexins and neuroligins934.8×6e-10
Protein-protein interactions at synapses526.0×3e-05
RHOA GTPase cycle57.3×5e-03

GO biological processes:

GO termPartnersFoldFDR
establishment or maintenance of epithelial cell apical/basal polarity1075.5×2e-14
protein localization to synapse659.7×9e-08
receptor clustering756.7×7e-09
regulation of postsynaptic membrane neurotransmitter receptor levels638.6×8e-07
cell-cell adhesion1013.2×4e-07
protein-containing complex assembly811.8×2e-05
regulation of small GTPase mediated signal transduction59.3×4e-03
protein localization to plasma membrane68.5×2e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

124 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance112
Likely benign7
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
3061841GRCh38/hg38 10q26.2-26.3(chr10:125976998-133427130)x1Pathogenic

SpliceAI

1825 predictions. Top by Δscore:

VariantEffectΔscore
10:133088910:ATGG:Adonor_loss1.0000
10:133088911:TGGTG:Tdonor_loss1.0000
10:133088913:G:GGdonor_gain1.0000
10:133088913:GTG:Gdonor_loss1.0000
10:133097099:GAG:Gdonor_gain1.0000
10:133097099:GAGG:Gdonor_loss1.0000
10:133097101:GGTG:Gdonor_loss1.0000
10:133097103:T:Gdonor_loss1.0000
10:133098630:C:CAacceptor_gain1.0000
10:133098636:ACAGC:Aacceptor_gain1.0000
10:133098637:C:Gacceptor_gain1.0000
10:133098637:CA:Cacceptor_loss1.0000
10:133098638:A:ACacceptor_loss1.0000
10:133098638:A:AGacceptor_gain1.0000
10:133098638:AGC:Aacceptor_gain1.0000
10:133098639:G:Aacceptor_loss1.0000
10:133098639:G:GAacceptor_gain1.0000
10:133098639:GC:Gacceptor_gain1.0000
10:133098639:GCG:Gacceptor_gain1.0000
10:133098639:GCGC:Gacceptor_gain1.0000
10:133098639:GCGCC:Gacceptor_gain1.0000
10:133098761:GCG:Gdonor_gain1.0000
10:133127327:GCGTA:Gdonor_gain1.0000
10:133127329:GTA:Gdonor_gain1.0000
10:133127332:G:GGdonor_gain1.0000
10:133128323:CCACA:Cacceptor_loss1.0000
10:133128324:CACA:Cacceptor_loss1.0000
10:133128326:CAGC:Cacceptor_loss1.0000
10:133128327:A:AGacceptor_gain1.0000
10:133128327:A:ATacceptor_loss1.0000

AlphaMissense

3616 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:133128723:G:AG299R0.994
10:133128723:G:CG299R0.994
10:133128756:C:AR310S0.994
10:133128636:T:AW270R0.992
10:133128636:T:CW270R0.992
10:133097061:T:CC31R0.991
10:133128757:G:CR310P0.990
10:133102739:T:AW100R0.989
10:133102739:T:CW100R0.989
10:133128351:A:CS175R0.989
10:133128353:C:AS175R0.989
10:133128353:C:GS175R0.989
10:133128690:A:CS288R0.989
10:133128692:C:AS288R0.989
10:133128692:C:GS288R0.989
10:133128762:G:CD312H0.989
10:133128703:G:AG292D0.987
10:133128724:G:AG299E0.986
10:133128763:A:CD312A0.986
10:133128763:A:TD312V0.985
10:133128646:G:AG273E0.984
10:133127283:C:AA151D0.983
10:133128702:G:CG292R0.983
10:133128645:G:TG273W0.982
10:133129490:G:CW554C0.982
10:133129490:G:TW554C0.982
10:133098716:T:CF70L0.981
10:133098718:C:AF70L0.981
10:133098718:C:GF70L0.981
10:133128332:C:GC168W0.981

dbSNP variants (sampled 300 via entrez): RS1000006828 (10:133107282 T>C), RS1000020339 (10:133129964 G>A,T), RS1000038962 (10:133118591 G>A,T), RS1000087381 (10:133103909 G>T), RS1000100230 (10:133114241 G>A), RS1000119936 (10:133104042 G>A,T), RS1000209338 (10:133115878 C>T), RS1000247223 (10:133095235 A>G), RS1000430373 (10:133114034 C>T), RS1000436387 (10:133100023 T>C), RS1000443095 (10:133107541 T>C), RS1000574950 (10:133112245 T>C), RS1000579786 (10:133087796 C>T), RS1000652578 (10:133108033 G>A), RS1000677929 (10:133122723 T>C)

Disease associations

OMIM: gene MIM:612302 | disease phenotypes: MIM:617330, MIM:126800

GenCC curated gene-disease

Mondo (2): hypotonia, ataxia, and delayed development syndrome (MONDO:0015021), Duane syndrome type 1 (MONDO:0024265)

Orphanet (2): Duane retraction syndrome (Orphanet:233), Developmental delay-ataxia-hypotonia-facial dysmorphism syndrome (Orphanet:658843)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST003264_771Post bronchodilator FEV1/FVC ratio3.000000e-07
GCST008369_14Plasma anti-thyroglobulin levels2.000000e-07

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004713FEV/FVC ratio

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523885 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Adhesion Class GPCRs

CTD chemical–gene interactions

12 total (human), top 12 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases methylation2
Tobacco Smoke Pollutiondecreases expression, decreases methylation2
bisphenol Adecreases methylation1
bisphenol Sdecreases methylation1
Resveratrolaffects cotreatment, decreases expression1
Air Pollutantsincreases abundance, affects methylation1
Arsenicaffects methylation1
Vehicle Emissionsaffects methylation, increases abundance1
Nitrogen Dioxideaffects methylation, increases abundance1
Plant Extractsaffects cotreatment, decreases expression1
Valproic Acidincreases methylation1
S-Nitrosoglutathioneincreases expression1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4883404BindingPRESTO-Tango GPCRome screening (GPR123)Data for DCP probe UCSF924

Cellosaurus cell lines

1 cell lines: 1 spontaneously immortalized cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_KX28PathHunter CHO-K1 GPR123 beta-arrestinSpontaneously immortalized cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.